Evidence map›Paper›PMID 35615932›Full record

ArticleHaematologica2022

Prolonged remission with pembrolizumab and radiation therapy in a patient with multisystem Langerhans cell sarcoma.

Saurabh Zanwar, Aishwarya Ravindran, Jithma P Abeykoon, Jason R Young, Timothy F Kozelsky, Karen L Rech, Gaurav Goyal, Ronald S Go

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Saurabh ZanwarDivision of Hematology, Mayo Clinic, Rochester, MN.
Aishwarya RavindranDivision of Hematopathology, Department of Laboratory Medicine and Pathology; Mayo Clinic, Rochester, MN.
Jithma P AbeykoonDivision of Hematology, Mayo Clinic, Rochester, MN.
Jason R YoungDepartment of Radiology, Mayo Clinic, Jacksonville, FL.
Timothy F KozelskyDivision of Radiation Oncology, Mayo Clinic Health System, Albert Lea, MN.
Karen L RechDivision of Hematopathology, Department of Laboratory Medicine and Pathology; Mayo Clinic, Rochester, MN.
Gaurav GoyalDivision of Hematology, Mayo Clinic, Rochester, MN; Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham. AL. ggoyal@uabmc.edu.
Ronald S GoDivision of Hematology, Mayo Clinic, Rochester, MN. go.ronald@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic Health System · USWinnMed · US

Funding

The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
NCI NIH HHS P50 CA097274
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Langerhans Cell SarcomaAntibodies, Monoclonal, HumanizedDisease-Free SurvivalHumansAntibodies, Monoclonal, Humanizedpembrolizumab

Identifiers

PMID35615932
PMCPMC9425309
OpenAlexW4281563857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.